An avoidable transmission of HIV from mother to child

CMAJ. Canadian Medical Association Journal

Volumn 183, Issue 6, 2011, Pages 690-692

  O'Bryan, Tyler ^a   Jadavji, Taj ^a   Kim, John ^b   Gill, M John ^a  

^a Southern Alberta HIV Clinic   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; NELFINAVIR; ZIDOVUDINE;

ADULT; AFRICA SOUTH OF THE SAHARA; ARTICLE; BOTTLE FEEDING; BREAST FEEDING; CASE REPORT; CD4 LYMPHOCYTE COUNT; CESAREAN SECTION; CONTINUOUS INFUSION; FEMALE; GESTATIONAL AGE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LOADING DRUG DOSE; PATIENT COMPLIANCE; PATIENT COUNSELING; POLYMERASE CHAIN REACTION; PREGNANCY; VERTICAL TRANSMISSION; VIRUS LOAD;

EID: 79953786509     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.091137     Document Type: Article

References (12)

1. Bartlett JG, Gallant JE. Medical management of HIV infection. Baltimore (MD): Johns Hopkins Medicine Health Publishing Business Group; 2007. p. 116-7.
2. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. Available: http://aidsinfo.nih. gov/ContentFiles/PerinatalGL.pdf (accessed 2009 Feb. 28).
3. Geelen S, Lange J, Borleffs J, et al. Failure to detect a non-B HIV-1 subtype by the HIV-1 Amplicor Monitor test, version 1.5: a case of unexpected vertical transmission. AIDS 2003;17:781-2. (Pubitemid 36521095)
4. Kim JE, Beckthold B, Chen Z, et al. Identification of a novel HIV type 1 subtype H/J recombinant in Canada with discordant HIV viral load (RNA) values in three different commercial assays. AIDS Res Hum Retroviruses 2007;23:1309-13.
5. Drexler JF, Souza Luna LK, Pedroso C, et al. Rates and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in Brazil. J Clin Microbiol 2007;45:2061-3. (Pubitemid 46933963)
6. Colebunders R, Hodossy B, Burger D, et al. The effect of highly active antiretroviral treatment on viral load and antiretroviral drug levels in breast milk. AIDS 2005; 19:1912-5. (Pubitemid 41546612)
7. Lehman DA, Chung MH, John-Stewart GC, et al. HIV-1 persists in breast milk cells despite antiretroviral treatment to prevent mother-to-child transmission. AIDS 2008; 22:1475-85.
8. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Available: www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf (accessed 2009 Feb. 28).
9. Hofmann J, De Allegri M, Sarker M, et al. Breast milk as the "water that supports and preserves life" - socio-cultural constructions of breastfeeding and their implications for the prevention of mother to child transmission of HIV in sub-Saharan Africa. Health Policy 2009;89:322-8.
10. Church D, Gregson D, Lloyd T, et al. HIV-1 viral load multi-assay comparison of the RealTime HIV-1, COBAS TaqMan 48 v. 1.0, Easy Q V1.2 and Versant V3.0 assays in a cohort of Canadian patients with diverse HIV subtype infections. J Clin Microbiol. In press.
11. Thorsen VC, Sundby J, Martinson F. Potential initiators of HIV-related stigmatization: ethical and programmatic challenges for PMTCT programs. Dev World Bioeth 2008;8:43-50. (Pubitemid 351334688)
12. Krentz H, Gill MJ. The five-year impact of an evolving global epidemic, changing migration patterns, and policy changes on a regional Canadian HIV population. Health Policy 2009;90:296-302.